Improving cancer treatment through advanced analytics and immunotherapy combinations
Administrative Core
This study is exploring new ways to improve cancer treatment for people with advanced skin melanoma by combining different therapies, and it brings together scientists from various top institutions to work together and share ideas.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute for Systems Biology NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10916303 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment strategies by integrating various scientific disciplines to study how sequential combinations of immunotherapy and targeted therapies can be effectively used against solid tumors, particularly metastatic cutaneous melanoma. The project involves collaboration among researchers from multiple prestigious institutions, utilizing advanced profiling tools and patient tissue samples to inform treatment approaches. By fostering communication and resource sharing among scientists, the initiative aims to streamline the development of innovative cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic cutaneous melanoma who may benefit from novel immunotherapy and targeted therapy combinations.
Not a fit: Patients with early-stage melanoma or those not eligible for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with advanced melanoma and potentially other solid tumors.
How similar studies have performed: Previous research has shown promising results in using combination immunotherapy approaches for cancer treatment, indicating potential success for this novel initiative.
Where this research is happening
Seattle, United States
- Institute for Systems Biology — Seattle, United States (Active)
Researchers
- Principal investigator: Heath, James R. — Institute for Systems Biology
- Study coordinator: Heath, James R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.